Financials in GBp. Standardized financial statements.
A compact view of how RUA Life Sciences plc turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £4.46M | £4.11M | £2.19M | £2.18M | £1.63M | £1.53M | £489,000 | £463,000 | £404,000 | £490,033 |
| Revenue Growth? | +8.4% | +87.7% | +0.6% | +34.1% | +6.3% | +212.5% | +5.6% | +14.6% | -17.6% | 0.0% |
| Cost of Revenue? | £1.40M | £941,000 | £475,000 | £746,000 | £580,000 | £548,000 | £0 | £0 | £0 | £224,148 |
| Gross Profit? | £3.06M | £3.17M | £1.72M | £1.43M | £1.04M | £980,000 | £489,000 | £463,000 | £404,000 | £265,885 |
| Gross Margin? | +68.6% | +77.1% | +78.3% | +65.8% | +64.3% | +64.1% | +100.0% | +100.0% | +100.0% | +54.3% |
| Operating Expenses? | £3.88M | £3.19M | £3.40M | £3.82M | £3.47M | £2.80M | £1.29M | £1.10M | £438,000 | £679,183 |
| Operating Income? | -£826,670 | -£989,000 | -£1.94M | -£2.31M | -£2.35M | -£1.80M | -£991,000 | -£632,000 | -£289,000 | -£198,726 |
| EBITDA? | -£383,335 | £401,000 | -£1.57M | -£1.95M | -£2.04M | -£1.28M | -£703,000 | -£391,000 | £185,000 | £42,219 |
| Income Before Tax | -£157,334 | -£10,000 | -£2.02M | -£2.32M | -£2.36M | -£1.59M | -£897,000 | -£609,000 | -£34,000 | -£189,149 |
| Income Tax Expense | -£2,000 | £11,000 | -£580,000 | -£319,000 | -£293,000 | -£143,000 | -£81,000 | -£2,141 | -£67,351 | -£57,346 |
| Net Income? | -£145,334 | £1,000 | -£1.44M | -£2.00M | -£2.07M | -£1.45M | -£816,000 | -£609,000 | -£34,000 | -£189,149 |
| EPS? | £-0.00 | £0.00 | £-0.04 | £-0.09 | £-0.09 | £-0.08 | £-0.06 | £-0.05 | £-0.01 | £-0.03 |
| Diluted EPS? | £-0.00 | £0.00 | £-0.04 | £-0.09 | £-0.09 | £-0.08 | £-0.06 | £-0.05 | £-0.01 | £-0.03 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality